The landscape of bispecific antibodies (BsAbs) is evolving rapidly, driven by increasing regulatory approvals and substantial industry investments. The
The landscape of bispecific antibodies (BsAbs) is evolving rapidly, driven by increasing regulatory approvals and substantial industry investments. The